• Suomeksi
  • For companies
    • For companies
    • Our approach
    • Investment process
  • For investors
    • For investors
    • Tesi as a co-investor
    • Fundraising process
    • KRR funds-of-funds
  • Investments
    • Investments
    • Companies
    • Funds
    • Cases
  • Team
  • News
    • News
    • Reports
    • Subscribe to newsletter
  • Market data
  • Sustainability
    • Sustainability
    • Responsible investment
    • Sustainability reporting
    • Materials and tools
    • Whistleblowing
  • About Tesi
    • About Tesi
    • Financials
    • Governance
    • Image bank
    • Tesi as a workplace
    • Contact and billing information
HomeCompaniesBiomensio Oy
Biomensio Oy
biomensio.com
Portfolio
Venture Capital Investments
Industry
Health & Life Science
Investment Year
2021

Biomensio is developing a bioanalysis-based Diagnostics-as-a-Service Platform. In the future, Biomensio’s digital reader can be used e.g. in traffic patrolling and for workplace drug testing, food safety measures, and anti-doping tests in sports.

Subscribe

* indicates required
How often would you like to hear from us? *

Marketing Permissions *

By accepting this form, you give Tesi and the partners who produce its newsletter permission to process your information with the newsletters. You can unsubscribe at any time by clicking the link in the footer of our emails or by contacting info@tesi.fi For information about our privacy practices, please visit our website https://www.tesi.fi/en/privacy-policy/.

Grow Together.
Tesi (Finnish Industry Investment Ltd)
Porkkalankatu 1, 00180 Helsinki
Privacy Policy